Alcohol remains one of the most frequently used intoxicants in the United States, especially among younger individuals [@bib1], [@bib2]. According to the National Epidemiologic Survey on alcoholism and related conditions, among 73% of human subjects aged 18 or older who drank, 46% consumed more than twice the number of drinks considered binge drinking at least once in the last year [@bib1]. Binge alcohol drinking, defined as having 4 or more drinks over 2 h on an occasion for women, or 5 or more drinks for men, is a major contributor of emergency department visits in the United States [@bib1]. There is also evidence that binge alcohol consumption can lead to development of life-threatening or fatal conditions [@bib3]. Apart from the severe indirect consequences, alcohol abuse has been shown to increase the risk of atrial fibrillation, acute myocardial infarction, and congestive heart failure to a similar degree as other well-known risk factors [@bib4]. Despite numerous studies investigating the effects of chronic moderate or excessive alcohol consumption on cardiovascular function and/or risk [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], relatively few reports have explored the cardiovascular effects of binge ethanol use and/or intoxication [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17]. Furthermore, these studies primarily focused on the determination of blood pressure or load- and/or heart rate--dependent indices of myocardial function measured by echocardiography (e.g., ejection fraction \[EF\]). Since alcohol is also known to time- and dose-dependently alter vascular function, heart rate, cardiac contractility, and peripheral resistance [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], reliance on load- and heart rate-dependent indices of contractile function may lead to inaccurate conclusions.

An increasing number of high school students and young adults have been reported to consume marijuana or synthetic cannabinoids \[a mixture of potent cannabinoid 1 receptor (CB1-R) agonists [@bib19], [@bib20]\] for recreational purposes, which may induce deleterious cardiovascular effects via CB1-R--dependent mechanisms [@bib21], [@bib22], [@bib23]. Moreover, synthetic cannabinoids are often consumed together with alcoholic beverages, leading to more severe outcomes and longer hospital stays [@bib24]. In the cardiovascular system, CB1-R is expressed in cardiomyocytes, endothelial and smooth muscle cells, and fibroblasts [@bib25], [@bib26], [@bib27], [@bib28], as well as in the peripheral and central autonomic nervous systems [@bib29]. The effects of synthetic cannabinoids acting via CB1-R have been well documented and may have robust impact on the cardiovascular system, leading to abnormalities in cardiac inotropy, chronotropy, conduction, and vascular tone [@bib21], [@bib29], [@bib30] \[for review see Montecucco et al. [@bib21] and Pacher et al. [@bib29]\]. Endocannabinoids do not appear to play a significant role in normal cardiovascular regulation, but when overproduced in various pathologic conditions (e.g., various forms of shock, cardiomyopathies, or heart failure and atherosclerosis) may contribute to hypotension, decreased cardiac contractility, and/or vascular inflammation and cell death through cardiovascular and macrophage CB1-R \[for review see Montecucco et al. [@bib21] and Pacher et al. [@bib29]\].

In this study, using multiple approaches and a well-established animal model, we aimed to identify and characterize the effects of acute alcohol intoxication on the cardiovascular system and to explore the potential role of the endocannabinoid--CB1-R signaling in mediating these effects. These results may have important implications for the management of the acute cardiovascular consequences of alcohol and mixed alcohol-synthetic cannabinoid intoxication.

Methods {#sec1}
=======

Animals {#sec1.1}
-------

Animal handling and usage were in accordance with the National Institutes of Health guidelines and experimental protocols were approved by our Institutional Animal Care and Use Committee of the National Institute on Alcohol Abuse and Alcoholism (Bethesda, Maryland). Eight- to 12-week-old male and female C57BL/6J mice were used (The Jackson Laboratory, Bar Harbor, Maine). NIAAA colony of male and female Cnr1^−/−^ (CB1^−/−^) and Cnr2^−/−^ (CB2^−/−^) mice on C57BL/6J background and their corresponding wild-type controls were also used in this study [@bib31], [@bib32]. A total number of 198 mice were used for the described experiments.

Drugs {#sec1.2}
-----

The CB1-R antagonist/inverse agonist rimonabant (SR141716) was purchased from Tocris (Tocris Bioscience, Bio-Techne, Minneapolis, Minnesota). Drugs were dissolved in dimethyl sulfoxide:Tocrisolve:saline solution at the ratio of 1:1:18 and vortexed to obtain a stable emulsion for bolus intravenous or intraperitoneal injections [@bib26]. Rimonabant was administered at the dose of 5 mg/kg.

Experimental design {#sec1.3}
-------------------

In the first set of experiments, a single alcohol binge (31.5% vol/vol, given at the dose of 5 g/kg body weight) or isocaloric maltodextrin solution were given to mice following 12 h of fasting as previously described [@bib33]. Cardiac function and hemodynamics were assessed 3 or 12 h after alcohol binge.

In the second set of experiments, the CB1-R antagonist/inverse agonist rimonabant (5 mg/kg) or its vehicle were administered intravenously to both alcohol- and maltodextrin-binged mice 3 h after binge (peak of cardiovascular effects) and hemodynamics were assessed for at least 15 consecutive minutes until the drug response stabilized. In other cohorts, the acute hemodynamic effects of binge alcohol drinking in CB1^−/−^ and CB2^−/−^ mice or in their wild-type controls were also investigated 3 h after acute alcohol exposure.

Pressure-volume catheterization and echocardiography {#sec1.4}
----------------------------------------------------

Left ventricular (LV) performance was assessed by using pressure-volume (P-V) approach [@bib34]. Briefly, a P-V catheter equipped with a 1-F size microtip (PVR-1045, Millar Instruments, Houston, Texas) was inserted into the right carotid artery and advanced into the LV. Polyethylene cannulas were also introduced into the right femoral artery and left jugular vein to measure mean arterial pressure (MAP) and to administer drugs, respectively. After stabilization, P-V signals were continuously recorded by using the PowerLab data acquisition system (ADInstruments Inc, Colorado Springs, Colorado). Multiple indices of load-dependent and load-independent LV function, MAP and total peripheral resistance (TPR) were calculated as previously described [@bib35]. Echocardiography was performed as previously reported [@bib36].

Arterial and microvascular blood flow measurements {#sec1.5}
--------------------------------------------------

Blood flow in both renal and superior mesenteric arteries were measured by using Transonic flow probes (MA0.5PSB and MA0.7PSB perivascular flowprobes, Transonic Systems Inc., Ithaca, New York) and were recorded and evaluated by using Powerlab LabChart (ADInstruments Inc., Colorado Springs, Colorado). Acral microcirculation was also assessed by using the laser speckle contrast imager moorFLPI-2 (Moor Instruments, Wilmington, Delaware).

Tissue endocannabinoid measurement {#sec1.6}
----------------------------------

Myocardial levels of anandamide (AEA), 2-arachidonyl glycerol (2-AG) were quantified by liquid chromatography/in-line mass spectrometry, as previously described [@bib26]. Values are expressed as femtomoles or picomoles per milligram of wet tissue.

Statistical analysis {#sec1.7}
--------------------

Results are expressed as mean ± SEM and plotted as bar graphs in all figures (see [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}, and [8](#fig8){ref-type="fig"} and [Supplemental Figures 1 to 6](#appsec1){ref-type="sec"}, except for [Supplemental Figures 2B](#appsec1){ref-type="sec"} \[pre-load recruitable stroke work or PRSW\], [Supplemental Figure 3A](#appsec1){ref-type="sec"} \[maximal slope of pressure increment or dP/dt~max~\], and [Supplemental Figure 4C](#appsec1){ref-type="sec"} \[TPR\], whereas data are presented as median ± 25th, 75th percentiles). Statistical significance between groups was determined by Student\'s *t* test or in case of multiple groups by 1-way analysis of variance followed by Dunnett's post hoc multiple comparison test to compare each group to control. Equality of variances was also examined by using either F-test of the equality of 2 variances or Brown-Forsythe test, respectively. If populations had different distribution, nonparametric tests (Mann-Whitney test for comparing 2 groups or Kruskal-Wallis test for multiple comparisons) were applied ([Supplemental Figures 2B, 3A, and 4C](#appsec1){ref-type="sec"}) to analyze data. Statistical significance was assessed by using GraphPad Prism 7 software (San Diego, California). Probability values of p \< 0.05 were considered significant.

Results {#sec2}
=======

A single alcohol binge induces cardiac dysfunction and redistribution of circulation {#sec2.1}
------------------------------------------------------------------------------------

Alcohol binge or intoxication may adversely impact both cardiac and vascular function (see introduction); therefore, we investigated the acute effects of alcohol binge on both load-dependent and load-independent indices of cardiac contractility (using echocardiography and P-V approaches) as well as on vascular blood flow in mesenteric and renal arteries and on skin microcirculation (using Transonic flow probes and/or laser speckle analysis) in vivo in mice.

In the first set of experiments, we attempted to characterize the time course of the effect of an acute alcohol binge on cardiovascular function and blood redistribution ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"}; [Supplemental Figures 1 to 3](#appsec1){ref-type="sec"}). First, we analyzed the effects of alcohol binge on cardiac function by echocardiography ([Supplemental Figure 1](#appsec1){ref-type="sec"}). Alcohol-induced transient reduction of stroke volume and cardiac output peaked around 3 h following the binge and largely recovered after 12 h ([Supplemental Figure 1](#appsec1){ref-type="sec"}). An acute binge had no significant effect on EF and fractional shortening measured by echocardiography. Since the latter parameters could be affected by loading conditions, which we hypothesized to change by alcohol binge, we further analyzed cardiac function using the P-V approach [@bib35], allowing determination of load-independent indices of LV contractile function. In parallel, we also determined peripheral circulation by measuring blood flow in superior mesenteric and renal arteries of mice by using Transonic flow probes and acral area and hindlimb microcirculation by laser-speckle imaging; the MAP and TPR were also calculated.Figure 1Binge Alcohol Induces Left Ventricular Dysfunction**(A)** Representative records of left ventricular (LV) pressure and its derivative (dP/dt) in control and alcohol-binged (EtOH 3h) mice, 3 h after maltodextrin or alcohol administration respectively. **(B)** Representative pressure-volume loops of control and alcohol-binged mice. **(C)** Systolic indices of LV performance \[maximal slope of pressure increment (dP/dt~max~), end-systolic pressure, stroke work, stroke volume, cardiac output and ejection fraction\] in control (ctrl) and alcohol-binged (EtOH 3h) mice. Data are expressed as mean ± SEM, n = 7 to 8; \*p \< 0.05 vs. control group.Figure 2Binge Alcohol Decreases Load-Independent Indices of Left Ventricular Function**(A)** Pressure-volume (P-V) loops of control and alcohol-binged mice after gradual preload reduction obtained by vena cava inferior occlusion. **Red lines** indicate the slope of end-systolic P-V relationship; **blue lines** display the slope of end-diastolic P-V relationship. **(B)** Load-independent indices of LV performance: end-systolic elastance (Ees), the dP/dt~max~-end-diastolic volume (EDV) relation and preload recruitable stroke work (PRSW). Data are expressed as mean ± SEM, n = 7 to 8; \*p \< 0.05 vs. control group. Abbreviation as in [Figure 1](#fig1){ref-type="fig"}.Figure 3Binge Alcohol Induces Vascular Dysfunction, Blood Redistribution, and Increased Cardiac Anandamide Levels**(A)** Mean arterial blood pressure and total peripheral resistance measured in control and alcohol-binged (EtOH 3h) mice 3 h after maltodextrin or alcohol administration, respectively. **(B)** Representative images of the jowl and hindlimb microcirculation in control and alcohol-binged mice. **Red color** indicates more intense, whereas **blue color** represents lower microcirculation. **Right panel** shows data on hindlimb microcirculation in control and alcohol-binged mice. **(C)** Superior mesenteric artery and renal artery blood flow changes in control and alcohol-binged mice. Data are expressed as mean ± SEM, n = 6 to 8; \*p \< 0.05 vs. control group. Abbreviation as in [Figure 1](#fig1){ref-type="fig"}.

P-V analysis revealed marked depression of both load-dependent ([Figure 1](#fig1){ref-type="fig"}) and load-independent ([Figure 2](#fig2){ref-type="fig"}) indices of LV contractile function 3 h following an acute alcohol binge, which largely recovered by 12 h ([Supplemental Figure 2](#appsec1){ref-type="sec"}). Acute alcohol binge also induced decrease of the MAP and TPR ([Figure 3A](#fig3){ref-type="fig"}), a consequence of decreased cardiac function ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) and marked redistribution of circulation (acral area and hindlimb vasodilation) ([Figure 3B](#fig3){ref-type="fig"}), and decreased mesenteric and renal blood flow ([Figure 3C](#fig3){ref-type="fig"}). There was no difference in the hemodynamic response to acute alcohol binge in male and female mice ([Supplemental Figure 3](#appsec1){ref-type="sec"}).

A single alcohol binge increases myocardial anandamide levels {#sec2.2}
-------------------------------------------------------------

Because numerous previous studies have shown that tissue injury and associated oxidative stress and inflammation can increase endocannabinoid levels in almost all organ systems and cell types (including myocardium, cardiomyocytes, activated endothelium, and inflammatory cells) and that endocannabinoid--CB1-R signaling promotes atherosclerosis and contributes to cardiovascular depressive state in various forms of shock, cardiomyopathies, heart failure, and liver cirrhosis [@bib21], [@bib29], we hypothesized that this signaling may also contribute to the acute cardiovascular effects of alcohol. We found that acute alcohol binge exposure time-dependently increased myocardial endocannabinoid AEA, but not 2-AG levels, peaking 3 h following acute alcohol administration ([Figure 4](#fig4){ref-type="fig"}) when the cardiac and vascular effects of alcohol were the most pronounced ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"}). Myocardial AEA levels returned to baseline 9 h after alcohol ingestion ([Figure 3D](#fig3){ref-type="fig"}) in parallel with the recovery of alcohol-induced cardiovascular dysfunction.Figure 4Binge Alcohol Increases Cardiac Anandamide LevelCardiac levels of anandamide (AEA) and 2-arachidonyl glycerol (2-AG) measured in control and alcohol-binged mice. Data are expressed as mean ± SEM, n = 5 to 6; \*p \< 0.05 vs. control group. Abbreviations as in [Figure 1](#fig1){ref-type="fig"}.

CB1-R signaling contributes to alcohol-induced acute cardiovascular effects {#sec2.3}
---------------------------------------------------------------------------

Because AEA is the endocannabinoid primarily exerting its effects on CB1-R, next we investigated the role of CB1-R signaling in the alcohol-induced cardiovascular effects by using a CB1-R antagonist/inverse agonist rimonabant and CB1-R knockout mice. Intravenous administration of rimonabant rapidly improved the 3-h alcohol intoxication-induced decrease of MAP, TPR, and superior mesenteric and renal artery blood flow, and attenuated the alcohol-induced peripheral vasodilation (hindlimb microcirculation) ([Figures 5A to 5C](#fig5){ref-type="fig"}). Rimonabant also markedly improved the alcohol binge--induced depression of load-dependent ([Figures 6A to 6C](#fig6){ref-type="fig"}) and load-independent ([Figures 7A and 7B](#fig7){ref-type="fig"}) indices of LV systolic function without exerting any effect in controls. The vehicle used had no hemodynamic effects in control or alcohol-binged groups ([Supplemental Figure 4](#appsec1){ref-type="sec"}). The marked alcohol-induced depression of load-independent indices of LV systolic function 3 h following the alcohol binge were also largely attenuated in CB1-R knockout mice ([Figure 8](#fig8){ref-type="fig"}). CB1-R deletion was also associated with improved load-dependent indices of LV contractile function as well as better preservation of blood pressure and TPR 3 h following an acute alcohol binge ([Supplemental Figure 5](#appsec1){ref-type="sec"}). In contrast, CB2-R deletion had no significant effects on the alcohol intoxication-induced cardiovascular effects ([Supplemental Figure 6](#appsec1){ref-type="sec"}). These results indicated that endocannabinoid--CB1-R, but not CB2-R signaling contributes to the acute hemodynamic effects of alcohol binge.Figure 5Cannabinoid 1 receptor Antagonist Attenuates the Binge Alcohol-Induced Vascular Changes**(A)** Mean arterial blood pressure and total peripheral resistance measured after 3 h in control or in alcohol-binged mice before (ctrl base and EtOH base, respectively) and 15 min after intravenous rimonabant (Rimo) (ctlr + Rimo and EtOH + Rimo, respectively) administration. **(B)** Hindlimb microcirculation in control or in alcohol-binged mice before (ctrl base and EtOH base, respectively) and 15 min after intravenous Rimo. **(C)** Superior mesenteric artery and renal artery blood flow changes in control and in alcohol-binged mice before the treatment (ctrl base and EtOH base, respectively) and 15 min after intravenous Rimo (ctlr + Rimo and EtOH + Rimo, respectively) administration. Data are expressed as mean ± SEM, n = 5 to 7; \*p \< 0.05 vs. corresponding control group; ^\#^p \< 0.05 vs. EtOH base group. CB1-R = cannabinoid 1 receptor; other abbreviations as in [Figure 1](#fig1){ref-type="fig"}.Figure 6CB1-R Blockade Attenuates the Binge Alcohol-Induced Contractile Dysfunction**(A)** Representative records of LV blood pressure changes and dP/dt in mice 3 h after either maltodextrin or alcohol binge alcohol binge following intravenous rimonabant (Rimo) (EtOH + Rimo) administration. **(B)** Representative pressure-volume (P-V) loops of maltodextrin and alcohol-binged mice before (**red and dark blue**, respectively) and 15 min after intravenous Rimo (ctrl + Rimo and EtOH + Rimo, **light green and dark green** loops, respectively) injection. **(C)** Systolic indices of LV performance \[maximal slope of pressure increment (dP/dt~max~), end-systolic pressure, stroke work\] in control and in alcohol-binged mice before (ctrl base and EtOH base, respectively) and 15 min after intravenous Rimo (ctlr + Rimo and EtOH + Rimo, respectively) administration. Data are expressed as mean ± SEM, n = 6 to 8; \*p \< 0.05 vs. corresponding control group; ^\#^p \< 0.05 vs. EtOH base group. Abbreviations as in [Figures 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}.Figure 7CB1-R blockade attenuates the binge alcohol induced depression of load-independent indices of left ventricular contractile function**(A)** Representative P-V loops obtained by gradual preload reduction obtained by vena cava occlusion of vehicle (veh) (ctrl + veh and EtOH + veh) or Rimo (ctrl + Rimo and EtOH + Rimo) treated mice 3 h after either oral alcohol or maltodextrin administration, respectively. **Red lines** indicate the slope of end-systolic P-V relationship, whereas **blue lines** depict the slope of end-diastolic P-V relationship **(B)** Load-independent indices of LV performance (Ees, the dP/dt~max~--end-diastolic volume (EDV) relation, and PRSW) in vehicle-treated control or alcohol-binged mice (ctrl base, or EtOH base, respectively); or in rimonabant (Rimo)-treated control or alcohol-binged mice (ctlr + Rimo, or EtOH + Rimo, respectively). Data are expressed as mean ± SEM, n = 5 to 6; \*p \< 0.05 vs. corresponding control group; ^\#^p \< 0.05 vs. EtOH base group. Abbreviations as in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [6](#fig6){ref-type="fig"}.Figure 8CB1-R Deletion Attenuates the Binge Alcohol Intoxication-Induced Cardiac Dysfunction**(A)** Representative P-V loops of alcohol-binged CB1^+/+^ and CB1^-/-^ mice after gradual preload reduction obtained by vena cava occlusion. **Red lines** indicate the slope of end-systolic P-V relationship, whereas **blue lines** show the slope of end-diastolic P-V relationship. **(B)** Load-independent indices of LV performance (Ees, the dP/dt~max~ -- EDV relation, and PRSW) in control or in alcohol-binged CB1^+/+^ and CB1^-/-^ mice. Data are expressed as mean ± SEM, n = 5 to 6; \*p \< 0.05 vs. corresponding control group; ^\#^p \< 0.05 vs. alcohol-binged CB1^+/+^ group. Abbreviations as in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [6](#fig6){ref-type="fig"}.

Discussion {#sec3}
==========

In the present study, we characterized in detail the binge alcohol intoxication-induced hemodynamic alterations (cardiac and peripheral effects) in mice in vivo by using echocardiography, the state-of-the-art pressure-volume catheterization, ultrasound flow probes, and laser speckle contrast approach.

The results of the current investigation provide several unique findings worthy of consideration. At first, acute alcohol binge intoxication in mice induced a profound decrease in LV contractile function accompanied with marked redistribution of peripheral circulation leading to decreased TPR and MAP, which peaked around 3 h following acute alcohol exposure and recovered 12 h later. Secondly, these hemodynamic effects were paralleled by time-dependent increases in myocardial endocannabinoid AEA levels. Thirdly, the acute inhibition of CB1-R with rimonabant dramatically improved alcohol-induced cardiac dysfunction, whereas this effect was widely diminished in CB1-R, but not CB2-R, knockout mice. Such observations strongly suggest a critical role of CB1-R activation of the peripheral vessels and the myocardium in mediating a hypotensive and cardiodepressive response to acute alcohol binge intoxication.

Heavy episodic alcohol drinking (also known as binge drinking) is a serious health problem in the United States [@bib2]. According to the latest surveys [@bib1] level I binge drinking is defined as 4 to 7 drinks for women, and 5 to 9 drinks for men; level II as 8 to 11 drinks for women and 10 to 14 drinks for men; and level III as 12 or more drinks for women and 15 or more drinks for men on a single occasion. Alcohol drinking at levels II and III is considered extreme binge drinking and is associated with increased number of alcohol-related emergency department visits as compared to non-binge drinkers [@bib1].

In this study, we used a single oral administration of an established dose of alcohol (5 g/kg) to mimic excessive human binge drinking [@bib33]. Consistent with previous reports using echocardiography, we found an alcohol-induced transient reduction of stroke volume and cardiac output with minimal effect on EF and fractional shortening ([Supplemental Figure 1](#appsec1){ref-type="sec"}). However, under altered loading conditions, heart rate assessment of cardiac function by using echocardiography is challenging and may lead to a variety of interpretation of the results [@bib35]. We used multiple additional approaches including measurements of renal and superior mesenteric arterial flow and acral microcirculation by flow probes and/or laser speckle imaging combined with P-V analysis and found that excessive alcohol binge led to a profound redistribution of peripheral circulation (decreased mesenteric and renal blood flow and increased acral microcirculation) as well as a decrease in myocardial contractile function. The alcohol-induced decrease of mesenteric and renal blood flow can be the consequence of either the activation of compensatory mechanisms (e.g., activation of the sympathetic nervous system) to counteract the peripheral vasodilation, decrease in blood pressure, and cardiac output; however, this can also be the consequence of markedly reduced cardiac output. Based on our results, the vasodilation induced by binge alcohol exposure may ultimately lead to alteration of loading conditions affecting cardiac output and macrovascular function, at least in part, via CB1-R--dependent mechanism. Furthermore, the alcohol-induced activation of myocardial AEA--CB1-R signaling may also decrease LV intrinsic contractility (determined by evaluation of load- and heart rate--independent indices of LV function) in vivo, further attenuating mean blood pressure and perhaps mesenteric and renal blood flow. These hemodynamic effects were peaking 3 h following the alcohol exposure (not different in male and female mice) and returned to baseline levels 12 h later. Similarly to our results, toxic doses of alcohol induced hypotension, decrease of TPR, and cardiac dysfunction in dogs [@bib13]. Human studies reported endothelial dysfunction and increases or biphasic effects on systolic blood pressure following binge alcohol consumption [@bib14], [@bib16], [@bib37]. In these studies, a relatively modest dose of alcohol was used.

Similar to the effects of binge alcohol drinking, increased endocannabinoid/CB1-R signaling has also been implicated in the impaired cardiac contractility associated with advanced liver cirrhosis [@bib38], [@bib39]. As liver cirrhosis often develops on a background of chronic alcoholism, the impairment of cardiac contractility may be compounded in such cases. It has been also documented that binge alcohol drinking induces acute myocardial injury, and increases myocardial lipid peroxidation and protein carbonylation in mice [@bib40]. Oxidative stress has been implicated in triggering endocannabinoid production in parenchymal tissues [@bib26], [@bib32] contributing to depression of cardiac function, vasodilation, or vasoconstriction [@bib26], [@bib29], [@bib41]. In this study we show that acute alcohol exposure is associated with time-dependent increases in myocardial endocannabinoid AEA levels, which correlate with cardiac dysfunction. We also show that intravenous administration of CB1-R antagonist rimonabant 3 h after binge alcohol administration (at a peak of the cardiodepressive effects) significantly improves cardiac performance as well as redistribution of circulation, indicating an important role of the CB1-R signaling in these pathologic effects, whereas rimonabant had no effects in control mice ([Figures 5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, and [7](#fig7){ref-type="fig"}). This is further substantiated by the resistance of CB1^-/-^ mice to alcohol intoxication-induced hemodynamic effects ([Figure 8](#fig8){ref-type="fig"}).

Besides alcohol, synthetic cannabinoid abuse is an emerging risk for youth with documented severe adverse cardiovascular consequences mediated by cardiovascular CB1-R [@bib29]. Synthetic cannabinoids are often consumed together with alcoholic beverages for recreational use, leading to more severe outcomes [@bib24], [@bib42].

Study limitations {#sec3.1}
-----------------

The in vivo study was performed in mice and mice known to metabolize alcohol faster and less sensitive to toxic effects of ethanol compared to dogs or humans. The hemodynamic effects of alcohol intoxication are complex and most likely also confounded by the time-dependent activation of various compensatory mechanism (e.g., sympathetic nervous system). In our study we performed detailed hemodynamic analysis only 3 and 12 h following the acute alcohol intoxication.

Conclusions {#s9000}
===========

Collectively, we show that excessive alcohol binge exerts complex and profound cardiovascular effects with transient (lasting for several hours) marked depression of myocardial contractile function. This may represent a problem in individuals with pre-existing cardiovascular disease, chronic alcohol consumption, or regular cannabis use [@bib29]. We also show that these hemodynamic effects involve endocannabinoid--CB1-R signaling, suggesting that repurposing CB1-R antagonists for combined alcohol-synthetic cannabinoid intoxication may save lives.Perspectives**COMPETENCY IN MEDICAL KNOWLEDGE:** Excessive binge alcohol drinking has adverse effects on cardiovascular function. Activation of CB1-R signaling is a crucial step towards the development of acute alcohol intoxication-induced adverse cardiovascular events.**TRANSLATIONAL OUTLOOK:** Since there is an increasing prevalence of alcohol ingestion alone, or in combination with synthetic cannabinoid use leading to adverse cardiovascular effects in adolescents, this emerging threat raises major health concerns, and targeting CB1-R signaling may evolve as an important therapeutic option in such conditions.

Appendix {#appsec1}
========

Supplemental Figures 1--6
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